Econ-Omics Talks: Evaluating and Valuing Pharmacogenetic Testing
February 11, 2025 @ 4:00 pm - 5:00 pm UTC+0
Professor Payne will present an overview of her research that has focussed on generating economic evidence to understand the potential impact of introducing pharmacogenetic testing into a healthcare system. Taking a UK focus, she will present examples of her work that illustrate some of the key challenges and uncertainties that need to be addressed when evaluating and valuing models of service delivery of pharmacogenetic testing. This presentation is part of the Econ-Omics Talks series and will include a brief speaker interview in addition to a research seminar.
About the Professor: Professor Katherine Payne (ORCID: 0000-0002-3938-4350) is an academic health economist with over 30-years applied and methodological research experience in the economic evaluation (using RCT and decision-analytic models) and valuation (using discrete choice experiments and contingent valuation) of health care interventions and specifically precision medicine and genomics. Katherine is also a registered pharmacist and in 2016 her contribution to the profession was recognised by the award of Fellow of the Royal Pharmaceutical Society. In April 2023, Katherine was awarded a National Institute for Health and Care Research (NIHR) Senior Investigator award recognising her as an outstanding leader of people-based research within the NIHR research community. She has a particular interest in the use of economic evidence to inform decision-making in practice and was a member of a National Institute for Health and Care Excellence (NICE) Technology Appraisal Committee between October 2003 and 2012. Katherine is a current member of the UK National Screening Committee Research and Methodology Group.